The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Clinical Diabetes
Volume 16 - 2025 |
doi: 10.3389/fendo.2025.1501323
The Role of Activated Partial Thrombin Time in Mediating the Impact of Poorly Glycemic Control on Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus
Provisionally accepted- 1 Henan University of Science and Technology, Luoyang, Henan Province, China
- 2 The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
- 3 Huzhou Central Hospital, Huzhou, China
- 4 Zhongda Hospital, Southeast University, Nanjing, Jiangsu Province, China
- 5 Jinzhou Medical University, Jinzhou, Liaoning Province, China
Aim: This study aims to investigate the role of activated partial thrombin time (APTT) as a potential mediator in the relationship between suboptimal glycemic control and diabetic peripheral neuropathy (DPN) in individuals with type 2 diabetes mellitus (T2DM).Methods: A total of 183 T2DM patients were enrolled in this study. Comprehensive clinical data, including coagulation parameters and nerve conduction velocity, were collected and compared between patients with and without DPN. Subsequent correlation and regression analyses were conducted to explore the associations among APTT, HbA1c levels, and nerve conduction velocities. Moreover, mediation analyses were performed to evaluate the total, direct, and indirect effects of HbA1c on specific nerve conduction velocities, with APTT serving as a mediator. Results: In comparison to 101 patients without DPN, 82 patients with DPN exhibited significantly elevated levels of HbA1c and decreased levels of APTT. Notably, levels of APTT and HbA1c were correlated with conduction velocities of Tibial nerve motor fibers, as well as sensory fibers of the Ulnar nerve, Median nerve, and Sural nerve. Furthermore, both elevated HbA1c and decreased APTT were identified as risk factors for DPN in T2DM individuals. Mediation analyses uncovered that the indirect effect of HbA1c on sensory fiber conduction velocities in the Ulnar and Sural nerves was mediated by APTT in T2DM patients.Mediation analysis showed that APTT mediated the indirect effect of HbA1c on the conduction velocities of sensory fibers in both the ulnar nerve and sural nerve (95% CI: -0.3448, -0.0135; -0.3523, -0.0180). APTT mediated the relationship between HbA1c and the conduction velocities of sensory fibers in the ulnar nerve or sural nerve by 34.66% or 22.03%, respectively.In patients with T2DM, uncontrolled HbA1c inadequate glycemic control and shorter APTT abnormal coagulation function emerges as risk factors for the development of DPN. Additionally, the impact of hyperglycemia on DPN may be partially mediated by alterations in APTT levels the effect of increased HbA1c upon DPN, especially for influenced conduction velocities of sensory fibers in both the ulnar nerve and sural nerve may partly medicated by decreased APTT..
Keywords: activated partial thrombin time, Diabetic peripheral neuropathy, type 2 diabetes mellitus, Hyperglycemia, Nerve conduction velocity
Received: 24 Sep 2024; Accepted: 02 Jan 2025.
Copyright: © 2025 Zhang, Chen, Sun, Zhu, Niu, Fareeduddin Mohammed Farooqui, Wang, Song, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Haoqiang Zhang, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.